NCT02192775View on ClinicalTrials.gov

UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus

PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

August 20, 2019

Study Completion Date

August 20, 2019

Conditions
Multiple Myeloma
Interventions
DRUG

MV-NIS

one dose in conjunction with a 4 day course intravenously

Trial Locations (1)

72205

University of Arkansas for Medical Science, Little Rock

All Listed Sponsors
lead

University of Arkansas

OTHER

NCT02192775 - UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus | Biotech Hunter | Biotech Hunter